26 / 30
26
14.
Weinstock-Guttman B, Miller C, Yeh E, Stosic
M, Umhauer M, Batra N, et al. Neuromyelitis
optica immunoglobulins as a marker of disease
activity and response to therapy in patients with
neuromyelitis optica. Mult Scler 2008;14:1061-7.
15.
Weinshenker BG, O'Brien PC, Petterson TM,
Noseworthy JH, Lucchinetti CF, Dodick DW, et
al. A randomized Trial of plasma Exchange in
acute central nervous system inflammatory
demyelinating disease. Ann Neurol 1999;46:878-
86.
16.
Keegan M, Pineda AA, McClelland RL, Darby
CH, Rodriguez M, Weinshenker BG. Plasma
Exchange for severe attacks of CNS
demyelination:
predictors
of
response.
Neurology 2002; 58:153-6.
17.
Bakker J, Metz L. Devic’s neuromyelitis optica
treated with intravenous gammaglobulin
(IVIG). Can J Neurol Sci 2004;31:265-7.
18.
Watanabe S, Nakashima I, Misu T, Miyazawa I,
Shiga Y, Fujihara K, et al. Therapeuthic efficacy
of plasma Exchange in NMO-IgG-positive
patients with neuromyelitis optica. Mult Scler
2007;13:128-32.
19.
Roed HG, Langkilde A, Sellebjerg F, Lauritzen
M, Bang P, Mørup A, et al. A double-blind,
randomized trial of IV immunoglobulin